1 Page 1 2 Page 2 3 Preview 4 Complete
Page 1 of 4 (0%)

Please note that completion of this evaluation form is required to receive credits.

Please complete the evaluation by answering all questions.
*
*
Were these learning objectives achieved?
Strongly AgreeAgreeNeutralDisagreeStrongly Disagree
Classify traditional compounding pharmacies and outsourcing facilities in order to understand the parameters of practice for each of these two compounding classifications that fall under the new Drug Quality and Security Act H.R. 3204.
Describe the infrastructure and subdivisions of a quality management system for compounding; System P and its related categories.
Identify the relevance and impact of Unites States Pharmacopeia chapters and their relationship to a non-hazardous and hazardous compounding practice.
Discuss roles and responsibilities, theoretical and practical skills, and performance verification-related testing required for personnel involved in non-hazardous and hazardous compounding.
Discuss engineering and architectural design concepts and requirements for the safe handling and management of non-hazardous and hazardous drugs.
Describe structural, functional, and operational primary and secondary engineering control requirements for the safe handling and management of non-hazardous and hazardous drugs.
Relate principles of air pressure differentials, airflow dynamics, and critical first air to sterile compounding.
Express the relevance of technology used in non-hazardous and hazardous drug compounding: electromechanical, reusable, disposable, personal protective equipment, safety, emergency, testing, 1 and deactivation/decontamination and disinfection equipment and supplies.
Recall procedures involved in the safe handling, maintenance, monitoring, testing and verification of a sterile compounding environment.
Describe protocols for the deactivation/decontamination and disinfection of ISO class environments for non-hazardous and hazardous drug compounding.
Outline the relative significance of process development as it applies to the development of a master formulation record.
Relate the function(s) of excipients to compounded sterile preparations.
Discuss clinical considerations that must be applied to sterile compounding to help to ensure patient safety in a patient-centric practice.
Discuss the components of a master formulation record used for compounded sterile preparations.
Recall pharmaceutical calculations used in a sterile compounding practice.
Repeat a comprehensive series of aseptic techniques related to the compounding of sterile preparations.
*
Were these learning objectives achieved?
Strongly AgreeAgreeNeutralDisagreeStrongly Disagree
Identify the differences between traditional compounding pharmacies and outsourcing facilities under the new Drug Quality and Security Act H.R. 3204.
Describe the infrastructure and subdivisions of a quality management system for compounding; System P and its related categories.
List Unites States Pharmacopeia chapters and their relationship to a non-hazardous and hazardous compounding practice.
List roles and responsibilities, theoretical and practical skills, and performance verification-related testing required in maintaining an appropriate level of competency when performing non-hazardous and hazardous compounding.
Recognize engineering and architectural design concepts required for the safe handling and management of non-hazardous and hazardous drugs.
Recognize structural, functional, and operational primary and secondary engineering controls when compounding and handling non-hazardous and hazardous drugs.
Relate principles of air pressure differentials, airflow dynamics, and critical first air to sterile compounding.
Identify relevant technology used in non-hazardous and hazardous drug compounding: electromechanical, reusable, disposable, personal protective equipment, safety, emergency, testing, and deactivation/decontamination and disinfection equipment and supplies.
Recall procedures involved in the safe handling, maintenance, monitoring, testing and verification of a sterile compounding environment.
Relate protocols for the deactivation/decontamination and disinfection of ISO class environments to non-hazardous and hazardous drug compounding activities.
Recognize the importance of process development leading to the development of a master formulation record.
Recognize the function(s) of excipients found in sterile preparation master formulation records.
Recognize clinical considerations a pharmacist-in-charge must consider to ensure patient safety in a patient-centric practice.
Explain how to follow and complete a master formulation record used for documenting compounded sterile preparations.
Recall pharmaceutical calculations used under the supervision of a pharmacist-in-charge in a sterile compounding practice.
Repeat a comprehensive series of aseptic techniques related to the compounding of sterile preparations.